{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T10:56:01Z","timestamp":1775559361614,"version":"3.50.1"},"reference-count":32,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2003,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The rapid exocytosis of von Willebrand factor (VWF) in response to vascular injury can be attributed to the fact that VWF is stored in the Weibel-Palade bodies (WPBs) of endothelial cells. We describe a system for examining the ability of VWF to drive both the formation of a storage compartment and the function of that compartment with respect to regulated secretion. Transient transfection of HEK293 cells with wild-type human VWF cDNA leads to the formation of numerous elongated organelles that resemble WPBs. These \u201cpseudo-WPBs\u201d exhibit the internal structure, as well as the ability to recruit membrane proteins including P-selectin, of bona fide WPBs. Finally, VWF was efficiently secreted upon stimulation by phorbol ester. We used this system to examine 3 VWF mutations leading to von Willebrand disease that affect VWF multimerization and constitutive secretion. Surprisingly we find that all 3 mutants can, to some extent, make pseudo-WPBs that recruit appropriate membrane proteins and that are responsive to secretagogues. The most striking defects are a delay in formation and a reduction in the length and number of pseudo-WPBs in proportion to the clinical severity of the mutation. Studies of pseudo-WPB formation in this system thus yield insights into the structure-function relationships underpinning the ability of VWF to form functional WPBs. (Blood. 2003;102:2452-2458)<\/jats:p>","DOI":"10.1182\/blood-2003-02-0599","type":"journal-article","created":{"date-parts":[[2003,6,10]],"date-time":"2003-06-10T00:22:11Z","timestamp":1055204531000},"page":"2452-2458","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":72,"title":["Analysis of intracellular storage and regulated secretion of 3 von Willebrand disease\u2013causing variants of von Willebrand factor"],"prefix":"10.1182","volume":"102","author":[{"given":"Gre\u0301goire","family":"Michaux","sequence":"first","affiliation":[{"name":"From the Medical Research Council (MRC) Laboratory for Molecular Cell Biology and Cell Biology Unit, University College London, London; and the Academic Unit of Haematology, Division of Genomic Medicine, Royal Hallamshire Hospital, Sheffield, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsay J.","family":"Hewlett","sequence":"additional","affiliation":[{"name":"From the Medical Research Council (MRC) Laboratory for Molecular Cell Biology and Cell Biology Unit, University College London, London; and the Academic Unit of Haematology, Division of Genomic Medicine, Royal Hallamshire Hospital, Sheffield, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah L.","family":"Messenger","sequence":"additional","affiliation":[{"name":"From the Medical Research Council (MRC) Laboratory for Molecular Cell Biology and Cell Biology Unit, University College London, London; and the Academic Unit of Haematology, Division of Genomic Medicine, Royal Hallamshire Hospital, Sheffield, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne C.","family":"Goodeve","sequence":"additional","affiliation":[{"name":"From the Medical Research Council (MRC) Laboratory for Molecular Cell Biology and Cell Biology Unit, University College London, London; and the Academic Unit of Haematology, Division of Genomic Medicine, Royal Hallamshire Hospital, Sheffield, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian R.","family":"Peake","sequence":"additional","affiliation":[{"name":"From the Medical Research Council (MRC) Laboratory for Molecular Cell Biology and Cell Biology Unit, University College London, London; and the Academic Unit of Haematology, Division of Genomic Medicine, Royal Hallamshire Hospital, Sheffield, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina E.","family":"Daly","sequence":"additional","affiliation":[{"name":"From the Medical Research Council (MRC) Laboratory for Molecular Cell Biology and Cell Biology Unit, University College London, London; and the Academic Unit of Haematology, Division of Genomic Medicine, Royal Hallamshire Hospital, Sheffield, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel F.","family":"Cutler","sequence":"additional","affiliation":[{"name":"From the Medical Research Council (MRC) Laboratory for Molecular Cell Biology and Cell Biology Unit, University College London, London; and the Academic Unit of Haematology, Division of Genomic Medicine, Royal Hallamshire Hospital, Sheffield, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"key":"2020021222510338800_REF1","doi-asserted-by":"crossref","unstructured":"Sadler JE. Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem. 1998;67: 395-424.","DOI":"10.1146\/annurev.biochem.67.1.395"},{"key":"2020021222510338800_REF2","doi-asserted-by":"crossref","unstructured":"Ruggeri ZM. Structure and function of von Willebrand factor. Thromb Haemost. 1999;82: 576-584.","DOI":"10.1055\/s-0037-1615883"},{"key":"2020021222510338800_REF3","doi-asserted-by":"crossref","unstructured":"Verweij CL, Diergaarde PJ, Hart M, Pannekoek H. Full-length von Willebrand factor (vWF) cDNA encodes a highly repetitive protein considerably larger than the mature vWF subunit. EMBO J. 1986;5: 1839-1847.","DOI":"10.1002\/j.1460-2075.1986.tb04435.x"},{"key":"2020021222510338800_REF4","doi-asserted-by":"crossref","unstructured":"Hannah MJ, Williams R, Kaur J, Hewlett LJ, Cutler DF. Biogenesis of Weibel-Palade bodies. Semin Cell Dev Biol. 2002;13: 313-324.","DOI":"10.1016\/S1084-9521(02)00061-7"},{"key":"2020021222510338800_REF5","doi-asserted-by":"crossref","unstructured":"van Mourik JA, Romani de Wit T, Voorberg J. Biogenesis and exocytosis of Weibel-Palade bodies. Histochem Cell Biol. 2002;117: 113-122.","DOI":"10.1007\/s00418-001-0368-9"},{"key":"2020021222510338800_REF6","doi-asserted-by":"crossref","unstructured":"McEver RP, Beckstead JH, Moore KL, Marshall-Carlson L, Bainton DF. GMP-140, a platelet alpha-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies. J Clin Invest. 1989;84: 92-99.","DOI":"10.1172\/JCI114175"},{"key":"2020021222510338800_REF7","doi-asserted-by":"crossref","unstructured":"Bonfanti R, Furie BC, Furie B, Wagner DD. PADGEM (GMP140) is a component of Weibel-Palade bodies of human endothelial cells. Blood. 1989;73: 1109-1112.","DOI":"10.1182\/blood.V73.5.1109.1109"},{"key":"2020021222510338800_REF8","doi-asserted-by":"crossref","unstructured":"Vischer UM, Wagner DD. CD63 is a component of Weibel-Palade bodies of human endothelial cells. Blood. 1993;82: 1184-1191.","DOI":"10.1182\/blood.V82.4.1184.1184"},{"key":"2020021222510338800_REF9","doi-asserted-by":"crossref","unstructured":"Denis CV, Andre P, Saffaripour S, Wagner DD. Defect in regulated secretion of P-selectin affects leukocyte recruitment in von Willebrand factor-deficient mice. Proc Natl Acad Sci U S A. 2001;98: 4072-4077.","DOI":"10.1073\/pnas.061307098"},{"key":"2020021222510338800_REF10","doi-asserted-by":"crossref","unstructured":"Sadler JE. A revised classification of von Willebrand disease. For the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost. 1994;71: 520-525.","DOI":"10.1055\/s-0038-1642471"},{"key":"2020021222510338800_REF11","doi-asserted-by":"crossref","unstructured":"Allen S, Abuzenadah AM, Blagg JL, et al. Two novel type 2N von Willebrand disease-causing mutations that result in defective factor VIII binding, multimerization, and secretion of von Willebrand factor. Blood. 2000;95: 2000-2007.","DOI":"10.1182\/blood.V95.6.2000"},{"key":"2020021222510338800_REF12","doi-asserted-by":"crossref","unstructured":"Allen S, Abuzenadah AM, Hinks J, et al. A novel von Willebrand disease-causing mutation (Arg273Trp) in the von Willebrand factor propeptide that results in defective multimerization and secretion. Blood. 2000;96: 560-568.","DOI":"10.1182\/blood.V96.2.560"},{"key":"2020021222510338800_REF13","doi-asserted-by":"crossref","unstructured":"Kaur J, Cutler DF. P-selectin targeting to secretory lysosomes of Rbl-2H3 cells. J Biol Chem. 2002;277: 10498-10505.","DOI":"10.1074\/jbc.M111293200"},{"key":"2020021222510338800_REF14","doi-asserted-by":"crossref","unstructured":"Norcott JP, Solari R, Cutler DF. Targeting of P-selectin to two regulated secretory organelles in PC12 cells. J Cell Biol. 1996;134: 1229-1240.","DOI":"10.1083\/jcb.134.5.1229"},{"key":"2020021222510338800_REF15","doi-asserted-by":"crossref","unstructured":"Blagoveshchenskaya AD, Hannah MJ, Allen S, Cutler DF. Selective and signal-dependent recruitment of membrane proteins to secretory granules formed by heterologously expressed von Willebrand factor. Mol Biol Cell. 2002;13: 1582-1593.","DOI":"10.1091\/mbc.01-09-0462"},{"key":"2020021222510338800_REF16","doi-asserted-by":"crossref","unstructured":"Simionescu N, Simionescu M. Galloylglucoses of low molecular weight as mordant in electron microscopy, I: procedure, and evidence for mordanting effect. J Cell Biol. 1976;70: 608-621.","DOI":"10.1083\/jcb.70.3.608"},{"key":"2020021222510338800_REF17","doi-asserted-by":"crossref","unstructured":"Hilbert L, Jorieux S, Proulle V, et al. Two novel mutations, Q1053H and C1060R, located in the D3 domain of von Willebrand factor, are responsible for decreased FVIII-binding capacity. Br J Haematol. 2003;120: 627-632.","DOI":"10.1046\/j.1365-2141.2003.04163.x"},{"key":"2020021222510338800_REF18","doi-asserted-by":"crossref","unstructured":"Ewenstein BM, Warhol MJ, Handin RI, Pober JS. Composition of the von Willebrand factor storage organelle (Weibel-Palade body) isolated from cultured human umbilical vein endothelial cells. J Cell Biol. 1987;104: 1423-1433.","DOI":"10.1083\/jcb.104.5.1423"},{"key":"2020021222510338800_REF19","doi-asserted-by":"crossref","unstructured":"Rosnoblet C, Ribba AS, Wollheim CB, Kruithof EK, Vischer UM. Regulated von Willebrand factor (vWf) secretion is restored by pro-vWf expression in a transfectable endothelial cell line. Biochim Biophys Acta. 2000;1495: 112-119.","DOI":"10.1016\/S0167-4889(99)00150-0"},{"key":"2020021222510338800_REF20","doi-asserted-by":"crossref","unstructured":"Dirks WG, MacLeod RA, Drexler HG. ECV304 (endothelial) is really T24 (bladder carcinoma): cell line cross-contamination at source. In Vitro Cell Dev Biol Anim. 1999;35: 558-559.","DOI":"10.1007\/s11626-999-0091-8"},{"key":"2020021222510338800_REF21","doi-asserted-by":"crossref","unstructured":"Haberichter SL, Fahs SA, Montgomery RR. von Willebrand factor storage and multimerization: 2 independent intracellular processes. Blood. 2000;96: 1808-1815.","DOI":"10.1182\/blood.V96.5.1808"},{"key":"2020021222510338800_REF22","doi-asserted-by":"crossref","unstructured":"Allen S, Goodeve AC, Peake IR, Daly ME. Endoplasmic reticulum retention and prolonged association of a von Willebrand's disease-causing von Willebrand factor variant with ERp57 and calnexin. Biochem Biophys Res Commun. 2001;280: 448-453.","DOI":"10.1006\/bbrc.2000.4139"},{"key":"2020021222510338800_REF23","doi-asserted-by":"crossref","unstructured":"Lyons SE, Bruck ME, Bowie EJ, Ginsburg D. Impaired intracellular transport produced by a subset of type IIA von Willebrand disease mutations. J Biol Chem. 1992;267: 4424-4430.","DOI":"10.1016\/S0021-9258(18)42852-9"},{"key":"2020021222510338800_REF24","doi-asserted-by":"crossref","unstructured":"Mayadas TN, Wagner DD. Vicinal cysteines in the prosequence play a role in von Willebrand factor multimer assembly. Proc Natl Acad Sci U S A. 1992;89: 3531-3535.","DOI":"10.1073\/pnas.89.8.3531"},{"key":"2020021222510338800_REF25","doi-asserted-by":"crossref","unstructured":"Kobayashi T, Vischer UM, Rosnoblet C, et al. The tetraspanin CD63\/lamp3 cycles between endocytic and secretory compartments in human endothelial cells. Mol Biol Cell. 2000;11: 1829-1843.","DOI":"10.1091\/mbc.11.5.1829"},{"key":"2020021222510338800_REF26","doi-asserted-by":"crossref","unstructured":"Griffiths G. What's special about secretory lysosomes? Semin Cell Dev Biol. 2002;13: 279-284.","DOI":"10.1016\/S1084-9521(02)00057-5"},{"key":"2020021222510338800_REF27","doi-asserted-by":"crossref","unstructured":"Rosenberg JB, Haberichter SL, Jozwiak MA, et al. The role of the D1 domain of the von Willebrand factor propeptide in multimerization of VWF. Blood. 2002;100: 1699-1706.","DOI":"10.1182\/blood-2002-03-0789"},{"key":"2020021222510338800_REF28","doi-asserted-by":"crossref","unstructured":"Wagner DD, Saffaripour S, Bonfanti R, et al. Induction of specific storage organelles by von Willebrand factor propolypeptide. Cell. 1991;64: 403-413.","DOI":"10.1016\/0092-8674(91)90648-I"},{"key":"2020021222510338800_REF29","doi-asserted-by":"crossref","unstructured":"Vischer UM, Wagner DD. von Willebrand factor proteolytic processing and multimerization precede the formation of Weibel-Palade bodies. Blood. 1994;83: 3536-3544.","DOI":"10.1182\/blood.V83.12.3536.3536"},{"key":"2020021222510338800_REF30","doi-asserted-by":"crossref","unstructured":"Marti T, Rosselet SJ, Titani K, Walsh KA. Identification of disulfide-bridged substructures within human von Willebrand factor. Biochemistry. 1987;26: 8099-8109.","DOI":"10.1021\/bi00399a013"},{"key":"2020021222510338800_REF31","doi-asserted-by":"crossref","unstructured":"Dong Z, Thoma RS, Crimmins DL, McCourt DW, Tuley EA, Sadler JE. Disulfide bonds required to assemble functional von Willebrand factor multimers. J Biol Chem. 1994;269: 6753-6758.","DOI":"10.1016\/S0021-9258(17)37439-2"},{"key":"2020021222510338800_REF32","doi-asserted-by":"crossref","unstructured":"Eikenboom JC, Matsushita T, Reitsma PH, et al. Dominant type 1 von Willebrand disease caused by mutated cysteine residues in the D3 domain of von Willebrand factor. Blood. 1996;88: 2433-2441.","DOI":"10.1182\/blood.V88.7.2433.bloodjournal8872433"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/102\/7\/2452\/1691118\/h81903002452.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/102\/7\/2452\/1691118\/h81903002452.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T11:11:57Z","timestamp":1623064317000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/102\/7\/2452\/17956\/Analysis-of-intracellular-storage-and-regulated"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10,1]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2003,10,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2003-02-0599","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,10,1]]}}}